Multiple Sclerosis Trial, Recruiting (NCT06665607)

Multiple Sclerosis Trial, Recruiting NCT06665607 Sponsor: Inés Llamas-Ramos Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT06665607 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been assessed as having a moderate level of disability related to a neurological condition, with a score between 3.0 and 6.0 on a standard disability scale used by doctors (confirm with trial site)

Who may not be able to join:

You have thinking or memory difficulties that could affect your ability to complete tests or questionnaires in the study
You have been diagnosed with a condition affecting your vision or your sense of balance (such as an inner ear disorder) that could affect your stability
Your Multiple Sclerosis medication has been changed in the 2 months before the study begins
You have had a sudden worsening of your Multiple Sclerosis symptoms (a relapse) in the 2 months before the study begins
You have a bone, joint, or muscle condition that could negatively affect your balance

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 620712485

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06665607

Sponsor: Inés Llamas-Ramos

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

Trial contact: 620712485

More information: https://clinicaltrials.gov/study/NCT06665607

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been assessed as having a moderate level of disability related to a neurological condition, with a score between 3.0 and 6.0 on a standard disability scale used by doctors (confirm with trial site)

Who may not be able to join:

You have thinking or memory difficulties that could affect your ability to complete tests or questionnaires in the study
You have been diagnosed with a condition affecting your vision or your sense of balance (such as an inner ear disorder) that could affect your stability
Your Multiple Sclerosis medication has been changed in the 2 months before the study begins
You have had a sudden worsening of your Multiple Sclerosis symptoms (a relapse) in the 2 months before the study begins
You have a bone, joint, or muscle condition that could negatively affect your balance

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Inés Llamas-Ramos

Registry

ClinicalTrials.gov

Start date

4 November 2024

Est. completion

30 June 2025

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Four Square Step Test (FSST): dynamic stability assessment test.; Six Spot Step Test (SSST): test that quantitatively assesses lower limb function; The Frailty and Injuries: Cooperative Studies of Intervention Tecnhiques (FICSIT-4 test): Test of static balance; Activities-specific Balance Confidence scale (AsBC)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov